Back to results
US 6,720,341 B2Granted
Preventives/remedies for kidney diseases
AssigneeMitsubishi Pharma Corporation
InventorsToshiki Moriyama, Enyu Imai
Life of this patent
Estimating the term…
Abstract
A compound having a Rho kinase inhibitory activity, such as (+)-trans-4-(1-aminoethyl)-1-(4-pyridylcarbamoyl)-cyclohexane, has a renal interstitial fibrosis inhibitory action in renal interstitial fibrosis model mice and various other actions, and therefore, is useful as an agent for the prophylaxis or treatment of renal diseases.
Claims6
A method for the prophylaxis or treatment of renal disease which accompanies renal fibrosis, which comprises administering a pharmaceutically effective amount of a compound having a Rho kinase inhibitory activity to a patient in need thereof.
Dependencies are inferred from the claim text.